Lixisenatide
Generic Name: lixisenatide
Manufactured by SANOFI-AVENTIS US. Dosage form: SOLUTION. Route: SUBCUTANEOUS. Active ingredients: LIXISENATIDE (0.3MG/3ML (0.1MG/ML)). Application: BLA208471.
Overview
Manufactured by SANOFI-AVENTIS US. Dosage form: SOLUTION. Route: SUBCUTANEOUS. Active ingredients: LIXISENATIDE (0.3MG/3ML (0.1MG/ML)). Application: BLA208471.
Dosage
Available as solution for subcutaneous use.
Related Medications
Berberis Aquifolium, Borax, Sepia, Kreosotum
berberis aquifolium, borax, sepia, kreosotum
Dosage form: LIQUID. Active ingredients: BERBERIS AQUIFOLIUM ROOT BARK (3 [hp_X]/mL); SEPIA OFFICINALIS JUICE (6 [hp_X]/mL); SODIUM BORATE (3 [hp_X]/mL); WOOD CREOSOTE (10 [hp_X]/mL). Category: DRUG FOR FURTHER PROCESSING.
Scandium Nitricum
scandium nitricum
Coxsackie B1 Nosode, Coxsackie B3 Nosode, Coxsackie B4 Nosode, Coxsackie B5 Nosode
coxsackie b1 nosode, coxsackie b3 nosode, coxsackie b4 nosode, coxsackie b5 nosode
Dosage form: LIQUID. Active ingredients: HUMAN COXSACKIEVIRUS B1 (1 [hp_M]/mL); HUMAN COXSACKIEVIRUS B3 (1 [hp_M]/mL); HUMAN COXSACKIEVIRUS B4 (1 [hp_M]/mL); HUMAN COXSACKIEVIRUS B5 (1 [hp_M]/mL). Category: DRUG FOR FURTHER PROCESSING.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.